Improved genetically modified Escherichia coli strain for prescreening antineoplastic agents.
Clinical experience suggests that drugs that interact with and damage DNA are useful in cancer chemotherapy (H. Umezawa , p. 43-72, in V. T. DeVita , Jr., and H. Busch [ed.], Methods in Cancer Research; Cancer Drug Development, vol. XVI, 1979). Prescreening systems for antitumor agents in natural pr...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1984
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185600/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6203484/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.5.622 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
